1. Home
  2. PDLB vs STRO Comparison

PDLB vs STRO Comparison

Compare PDLB & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ponce Financial Group Inc.

PDLB

Ponce Financial Group Inc.

HOLD

Current Price

$16.83

Market Cap

379.9M

Sector

N/A

ML Signal

HOLD

Logo Sutro Biopharma Inc.

STRO

Sutro Biopharma Inc.

HOLD

Current Price

$24.57

Market Cap

338.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDLB
STRO
Founded
1960
2003
Country
United States
United States
Employees
N/A
131
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
379.9M
338.9M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
PDLB
STRO
Price
$16.83
$24.57
Analyst Decision
Buy
Analyst Count
0
8
Target Price
N/A
$26.38
AVG Volume (30 Days)
60.2K
169.2K
Earning Date
04-24-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
160.87
N/A
EPS
1.20
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$13.45
P/E Ratio
$13.93
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.88
$0.52
52 Week High
$18.01
$27.96

Technical Indicators

Market Signals
Indicator
PDLB
STRO
Relative Strength Index (RSI) 62.22 62.63
Support Level $15.92 $0.76
Resistance Level $17.13 $27.96
Average True Range (ATR) 0.28 2.14
MACD 0.05 -0.06
Stochastic Oscillator 83.72 78.23

Price Performance

Historical Comparison
PDLB
STRO

About PDLB Ponce Financial Group Inc.

Ponce Financial Group Inc, is a United States-based holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in mortgage loans, consisting of one-to-four-family residential, multi-family residential, non-residential property and construction and land, and, to a lesser extent, business, and consumer loans. The company also invests in securities, which consists of securities issued by the U.S. Government and federal agencies and mortgage-backed securities issued by the United States government-sponsored enterprises. Some of the products and services include checking solutions, online and mobile banking, merchant credit card services, and others.

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Share on Social Networks: